Grown Rogue International (GRUSF) Current Assets (2011 - 2026)
Grown Rogue International (GRUSF) posted quarterly Current Assets of $24.9 million for Q1 2026, down 8.41% year-over-year from $27.1 million in Q1 2025, and up 12.07% quarter-over-quarter from $22.2 million in Q4 2025.
Grown Rogue International (GRUSF) Current Assets (2011 - 2026) Analysis & Trends
Grown Rogue International's Current Assets history runs 16 years deep, the most recent figure standing at $24.9 million for Q1 2026.
- In Q1 2026, Current Assets fell 8.41% year-over-year to $24.9 million; the TTM figure through Mar 2026 stood at $24.9 million (down 8.41% YoY), while the FY2025 annual figure was $22.2 million, up 69.1% from the prior year.
- Current Assets for Q1 2026 stood at $24.9 million, up from $22.2 million in the prior quarter.
- The five-year high for Current Assets was $31815.8 billion in Q3 2025, with the low at $6.0 million in Q4 2022.
- The 5-year median for Current Assets is $15.7 million (2023), against an average of $2272.6 billion.
- The sharpest annual moves came in 2025 and 2026: Current Assets jumped 228661551.88% in 2025, then retreated 8.41% in 2026.
- Grown Rogue International's Current Assets stood at $6.0 million in 2022, then surged by 92.56% to $11.5 million in 2023, then climbed by 14.37% to $13.1 million in 2024, then jumped by 69.1% to $22.2 million in 2025, then grew by 12.07% to $24.9 million in 2026.
- Business Quant data shows GRUSF's Current Assets at $24.9 million in Q1 2026, $22.2 million in Q4 2025, and $31815.8 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | 5.76 Bn |
| 2 | Teva Pharmaceutical Industries | 43.42 Bn | 39.76 Bn | 2.15 Bn | 13.76 Bn |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn | 6.36 Bn |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.98 Bn | 5.10 Bn | 19.76 Bn |
| 5 | United Therapeutics | 22.29 Bn | 19.63 Bn | 683.80 Mn | 3.48 Bn |
| 6 | Viatris | 18.78 Bn | 17.89 Bn | 1.46 Bn | 10.06 Bn |
| 7 | Neurocrine Biosciences | 15.66 Bn | 15.27 Bn | 935.80 Mn | 1.64 Bn |
| 8 | Elanco Animal Health | 11.91 Bn | 11.38 Bn | 798.00 Mn | 3.80 Bn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | 3.22 Bn |
| 10 | Grown Rogue International | 116.22 Mn | 104.68 Mn | 5.37 Mn | 22.55 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 22.55 Mn |
| Mar 31, 2026 | 24.86 Mn |
| Dec 31, 2025 | 22.18 Mn |
| Sep 30, 2025 | 31,815.77 Bn |
| Jun 30, 2025 | 26.78 Mn |
| Mar 31, 2025 | 27.14 Mn |
| Dec 31, 2024 | 13.12 Mn |
| Sep 30, 2024 | 13.91 Mn |
| Jun 30, 2024 | 13.12 Mn |
| Mar 31, 2024 | 20.04 Mn |
| Dec 31, 2023 | 11.47 Mn |
| Oct 31, 2023 | 17.42 Mn |
| Jul 31, 2023 | 12.85 Mn |
| Jan 31, 2023 | 10.18 Mn |
| Oct 31, 2022 | 5.96 Mn |
| Oct 31, 2021 | 1,453.00 |
| Apr 30, 2021 | 3.63 Mn |
| Jan 31, 2021 | 2.71 Mn |
| Oct 31, 2020 | 74,961.00 |
| Jul 31, 2020 | 1.91 Mn |